MétaCan
Menu
Back to cohort
Record W2792023491 · doi:10.1093/jcag/gwy009.114

A114 SYSTEMATIC REVIEW AND META-ANALYSIS: ENDOSCOPIC AND HISTOLOGIC PLACEBO RATES IN INDUCTION AND MAINTENANCE TRIALS OF ULCERATIVE COLITIS

2018· article· en· W2792023491 on OpenAlexaff
Christopher Ma, Leonardo Guizzetti, Remo Panaccione, Richard N. Fedorak, Claire E. Parker, Tran M Nguyen, Reena Khanna, Brian G. Feagan, Vipul Jairath

Bibliographic record

VenueJournal of the Canadian Association of Gastroenterology · 2018
Typearticle
Languageen
FieldMedicine
TopicMicroscopic Colitis
Canadian institutionsWestern UniversityUniversity of AlbertaRobarts Clinical TrialsUniversity of Calgary
Fundersnot available
KeywordsPlaceboMedicineInternal medicineClinical trialConfidence intervalMeta-analysisRandomized controlled trialUlcerative colitisClinical endpointGastroenterologySurgeryDiseasePathology

Abstract

fetched live from OpenAlex

Treatment targets in ulcerative colitis (UC) have evolved to include normalization of objective endoscopic and histologic endpoints. Minimizing the endoscopic and histologic placebo response and remission rate is critical for the conduct of efficient randomized controlled trials (RCTs) and development of new treatments, in order to maximize ability to detect differences between active comparator and placebo. To quantify the endoscopic and histologic placebo response and remission rates in induction and maintenance UC RCTs and to identify trial design factors influencing these rates. MEDLINE, EMBASE, and the Cochrane Library were searched from inception through March 1, 2017 for placebo-controlled RCTs of adult patients with UC treated with aminosalicylates, immunosuppressants, corticosteroids, biologics, and oral small molecules. Endoscopic and histologic placebo response and remission rates for induction and maintenance trials were pooled using a random-effects model. Patient- and trial-level covariates were evaluated by constructing stratum-specific rates of placebo response/remission and by random-effects meta-regression analysis. Placebo endoscopic response/remission rates were reported in 45 induction and eight maintenance trials; placebo histologic response/remission rates were reported in nine induction trials. Pooled estimates for placebo induction endoscopic remission, induction endoscopic response, and maintenance endoscopic remission rates were 25% [95 confidence interval (CI): 22–30%], 36% [29–43%], and 20% [16–24%], respectively. The pooled histologic remission rate in induction trials was 16% [10–25%]. Disease severity, disease duration, trial setting, trial phase, class of active comparator, trial follow-up duration, and endoscopic sub-score criterion for trial inclusion were not predictive of placebo endoscopic or histologic remission rates. Pooled placebo endoscopic and histologic response and remission rates vary according to whether trials are designed for induction or maintenance. Potential strategies to further reduce these rates include standardization of histologic scoring as well as the definitions used for response and remission. Figure 1: Forest plot of induction trials reporting placebo endoscopic remission rates, pooled using random-effects model. None

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.053
metaresearch head score (Gemma)0.123
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.053
Threshold uncertainty score0.283

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0530.123
Meta-epidemiology (narrow)0.0040.002
Meta-epidemiology (broad)0.0270.055
Bibliometrics0.0120.013
Science and technology studies0.0010.001
Scholarly communication0.0060.004
Open science0.0030.002
Research integrity0.0030.003
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.037
GPT teacher head0.306
Teacher spread0.268 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the Canadian Association of GastroenterologySame topicMicroscopic ColitisFrench-language works237,207